ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype.

David M Gershenson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.